Patents by Inventor Michael Nardi

Michael Nardi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and Stiffeners for Package Level Warpage Modulation
    Publication number: 20250062168
    Abstract: The present disclosure is directed to a patterned stiffener that includes a metallic body, which is a component of and is attached to a semiconductor device platform for providing rigidity. In an aspect, there are patterned sections formed on the metallic body that act to modulate the metallic body to obtain a desired configuration for the semiconductor device platform. In another aspect, the present disclosure is also directed to a method that includes providing a platform for forming an electronic component, disposing a stiffener having a metallic body on the platform, disposing at least one semiconductor device onto the platform, performing one or more bonding process steps, and exposing the stiffener to localized heating to modulate changes in the stiffener to a pre-determined shape or desired configuration.
    Type: Application
    Filed: August 18, 2023
    Publication date: February 20, 2025
    Inventors: Justin WHETTEN, Zhou YANG, Zheng KANG, Haowen LIU, Bassam ZIADEH, Vijay Krishnan SUBRAMANIAN, John HARPER, Pramod MALATKAR, Patrick NARDI, Anthony MONTERROSA, Michael TAN, Sean BUSHELL
  • Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders
    Patent number: 8753631
    Abstract: The present invention is directed to a therapeutic agent comprising a GPIIIa(49-66) specific targeting agent and a thrombi-specific homing agent. Also disclosed is the use of the therapeutic agent in carrying out a method of treating thromboembolic disorders and a method of inducing platelet fragmentation.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: June 17, 2014
    Assignee: New York University
    Inventors: Simon Karpatkin, Michael Nardi, Zongdong Li
  • AGENTS THAT DISSOLVE ARTERIAL THROMBI
    Publication number: 20110052594
    Abstract: Agents that induce platelet fragmentation include an IgG antibody that reacts with platelet epitope GPIIIA49-66 on platelet membrane, recombinant AMANTS-18, phorbol 12-myristate 13-acetate (PMA) and A23817.
    Type: Application
    Filed: February 11, 2009
    Publication date: March 3, 2011
    Applicant: NEW YORK UNIVERSITY
    Inventors: Simon Karpatkin, Michael Nardi
  • THERAPEUTIC AGENTS FOR INDUCING PLATELET FRAGMENTATION AND TREATING THROMBOEMBOLIC DISORDERS
    Publication number: 20110045008
    Abstract: The present invention is directed to a therapeutic agent comprising a GPIIIa(49-66) specific targeting agent and a thrombi-specific homing agent. Also disclosed is the use of the therapeutic agent in carrying out a method of treating thromboembolic disorders and a method of inducing platelet fragmentation.
    Type: Application
    Filed: April 30, 2010
    Publication date: February 24, 2011
    Applicant: NEW YORK UNIVERSITY
    Inventors: Simon Karpatkin, Magaret Karpatkin, Michael Nardi, Zongdong Li
  • Agents that dissolve arterial thrombi
    Publication number: 20070009529
    Abstract: Agents that induce platelet fragmentation include an IgG antibody that reacts with platelet epitope GPIIIA49-66 on platelet membrane, recombinant AMANTS-18, phorbol 12-myristate 13-acetate (PMA) and A23817.
    Type: Application
    Filed: June 22, 2006
    Publication date: January 11, 2007
    Applicant: New York University
    Inventors: Simon Karpatkin, Michael Nardi
  • Antibodies that dissolve arterial thrombi
    Publication number: 20040236079
    Abstract: An IgG antibody which induces platelet fragmentation. The antibody reacts with platelet epitope GPIIIa49-66 on platelet membranes. This antibody, or a monoclonal antibody derived from the GPIIIa49-66 epitope, will dissolve arterial thrombi generally found in the coronary arteries of patients with acute myocardial infarction as well as other arterial occlusions.
    Type: Application
    Filed: July 20, 2004
    Publication date: November 25, 2004
    Inventors: Simon Karpatkin, Michael Nardi
  • Orange tree name ‘Villa11’
    Patent number: PP33249
    Abstract: A new orange tree named ‘Villa11’ characterized by its late-maturing fruit.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: July 13, 2021
    Inventors: Frank Mercuri, Domenic Mercuri, Frank Nardi, Michael Nardi, Joe Nardi